![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 33, 30575-30578, August 17, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
andFrom the Departments of Chemistry and Molecular and Cell Biology, University of California, Berkeley, California 94720
Received for publication, March 21, 2001, and in revised form, May 22, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Bovine lysyl oxidase (BLO) contains two
different cofactors, copper (Kagan, H. M. (1986) in Biology
of Extracellular Matrix (Mecham, R. P., ed) Vol. 1, pp.
321-398, Academic Press, Orlando, FL) and lysine tyrosyl
quinone (LTQ) (Wang, S. X., Mure, M., Medzihradszky, K. F.,
Burlingame, A. L., Brown, D. E., Dooley, D. M., Smith, A. J., Kagan, H. M., and Klinman, J. P. (1996)
Science 273, 1078-1084). By a combination of
UV-visible spectroscopy, metal content analysis, and activity
measurements, we find that copper-depleted BLO reacts in an
irreversible manner with phenylhydrazine, an amine substrate analog,
and catalyzes multiple turnovers of the substrate benzylamine. After
removal of the majority of enzyme-bound copper, apoBLO exhibits a decrease in the LTQ content, as evidenced by the drop of the 510-520-nm absorbance, suggesting that the copper may play a
structural role in stabilizing the LTQ. The remaining intact LTQ in the
apoBLO reacted with phenylhydrazine, both in the presence and absence of the chelator, 10 mM 2,2'-dipyridyl. When benzylamine was
used as the substrate, the apoBLO turned over at a rate of 50-60% of the native BLO (after correction for the residual copper and the change
of LTQ content). Copper contamination from the assay buffer was ruled
out by comparison of enzyme activity using different apoBLO
concentrations. These studies demonstrate that the mature form of lysyl
oxidase retains many of its functions in the absence of copper.
Protein-lysine 6-oxidase (lysyl oxidase, LO; EC
1.4.3.13)1 is an
extracellular matrix protein. It has been assigned to the copper amine
oxidase family based on the presence of copper and its catalysis
of the oxidative deamination of amine to aldehyde (1, 2). It is well
established that decreased LO activity in connective tissues is
observed in diseases of impaired copper metabolism, such as the human
type IX Ehlers-Danlos syndrome and Menke's syndrome, both of which are
chromosome X-linked, recessively inherited disorders (2, 3). In
vitro assays of LO, using tritium-labeled elastin (prepared from
chick embryo aorta) as substrate, have led to the conclusion that lysyl
oxidase requires copper for enzyme turnover (4-6). From the data of
Gacheru et al. (6) obtained for purified bovine lysyl
oxidase (BLO), it was proposed that a single copper atom in lysyl
oxidase monomer is essential for the catalytic function and possibly
for the structural integrity of the enzyme (6).
Recently, the lysine tyrosyl quinone (LTQ) has been identified as the
active site carbonyl cofactor in bovine lysyl oxidase (7). Using the
UV-visible spectra of LTQ as a probe, we now report the effects of
copper removal on the reactivity of BLO with benzylamine and its
analog, phenylhydrazine. For the first time, it is observed that BLO
retains its ability to interact with amines in the absence of copper.
These results are related to the studied role for copper in the
analogous 2,4,5-trihydroxyphenylalanine-containing copper amine
oxidases (8, 9). We propose that the established physiological
requirement for copper in LO (3) is a consequence of an essential role
for copper in LTQ biogenesis, together with a role for copper in the
maintenance of cofactor and/or protein structural integrity.
Enzyme Purification and Activity Assay--
Lysyl oxidase was
purified from bovine aorta using a modified
procedure.2 The modified
method yielded more reproducible results, which are less
dependent on the tissue sources, as compared with the published method
(10). The final purified lysyl oxidase is a two-banded material with
the contaminant band content ranging from 10 to 50% of the total
protein concentration as estimated from the relative density of the
Coomassie-stained bands in SDS-PAGE gels. Earlier studies showed that
the contaminating band is free of LTQ (7). The specific activity of the
BLO was assayed in a buffer of 1.2 M urea, 16 mM potassium Pi (pH 7.8), and 10 mM benzylamine at 37 °C. The production of benzaldehyde
was monitored by the change in absorbance of 250 nm, using 12,800 M Preparation of Copper-free Lysyl Oxidase (apo-lysyl
oxidase)--
The removal of copper from bovine lysyl oxidase was
similar to that described by Gacheru et al. (6) with some
changes. Specifically, the enzyme was dialyzed first in a chelating
buffer containing 6 M urea, 16 mM potassium
Pi, 10 mM 2,2'-dipyridyl, pH 7.8, at 4 °C
overnight and then against the buffer of 6 M urea, 16 mM potassium Pi, pH 7.8, extensively for
24 h. Except for the 2,2'-dipyridyl-containing dialysis buffer,
the buffers used for apoBLO preparation and assay were run through
columns packed with chelating resin (Chelex 100; Sigma) to remove
residual copper. Trace metal analysis was performed with a PerkinElmer
Life Sciences 300DV inductively coupled plasma-atomic emission
spectrometer, using commercially available metal standard solution. The
copper content of buffers was found to be below 0.1 µM
(<6 ppb), close to the detection limit. For the activity assay with
two different apoBLO concentrations, the apoBLO was dialyzed against a
buffer of 3 M urea, 16 mM potassium
Pi, pH 7.8, after removal of copper by
2,2'-dipyridyl-containing buffer.
Reaction of the Apo-bovine Lysyl Oxidase with
Phenylhydrazine--
BLO has been shown to catalyze amine
oxidation via a ping-pong mechanism (11). To examine the copper
dependence of the reductive half-reaction, we first tested the
accessibility of the LTQ cofactor in both the native and apoBLO to the
substrate analog and irreversible inhibitor, phenylhydrazine.
Table I shows that in the native BLO, the copper content was 11 µM, and the molar ratio of
copper to enzyme was about 1:1 (Table I). The LTQ content of the native BLO was 6 µM, meaning that about 50% of the native
enzyme was titratable by phenylhydrazine and was catalytically
functional, consistent with previous reports (7, 12). As shown in Fig. 1A, in the presence of 10 mM 2,2'-dypyridyl, the apoBLO reacted with phenylhydrazine
and formed a derivative, which absorbed at 454 nm. The copper and zinc
contents in the reaction mixture were found to be 0.52 and 0.71 µM (Table I), respectively, which is much less than the
amount of the LTQ (4.7 µM). Without the chelator, 2,2'-dipyridyl, the apoBLO also reacted well with phenylhydrazine (Fig.
1B). If the enzyme was denatured with 1% SDS before
addition of phenylhydrazine, no appearance of the 454-nm peak was
observed within 20 min (not shown). These results indicate that the
reaction of phenylhydrazine with the LTQ in the apoBLO is
conformation-specific and that transition metal ions such as copper or
zinc are not required to keep the LTQ in the correct conformation(s)
for reaction with phenylhydrazine. These findings contrast with those
observed for the yeast amine oxidase from Hansenula
polymorpha expressed in Saccharomyces cerevisiae (HPAO)
(9). It was found that the apo-form of HPAO cannot react with
phenyhydrazine until Cu2+, Zn2+, or
Co2+ are added back to the enzyme. It has been suggested
that the binding of a metal ion to the active site of HPAO alters the
conformation such that it can react with phenylhydrazine. Because the
LTQ cofactor has a cross-linked structure (between a tyrosine and a
lysine side chain (7)), it is likely that the LTQ in BLO is more rigid than the TPQ in HPAO, such that metal ions are not required to orient
the LTQ for the reaction with phenylhydrazine.
However, as shown in Table I, the amount of the LTQ that can be
titrated by phenylhydrazine does decrease as the copper in the enzyme
was removed. The LTQ content reached 4.7 µM, about 74%
of that of the native BLO, after dialysis against chelating buffer. The
amount of LTQ decreased further to 4 µM, 65% of the original after removal of the chelator. Under certain conditions such
as lowering the pH (<7.0) of the chelating buffer, the final apoBLO
showed little absorbance at 510-520 nm (Fig.
2A), and its reactivity with
phenylhydrazine was down to the base-line level (Fig. 2B).
Addition of Cu (II) ion to this apoBLO preparation did not restore the
LTQ peak or its reactivity with phenylhydrazine (data not shown).
Noticeably, a new peak at 350 nm appeared in all the apoBLO
preparation. Although the exact nature of this new peak still remains
to be explored, it is likely derived from the modification of the LTQ
and probably represents an unreactive form of LTQ following copper
removal at reduced pH levels. As shown in Fig.
3, the preparation of apoBLO that was no
longer reactive toward phenylhydrazine was still able to conduct redox cycling, suggesting that the modified LTQ in this apoBLO preparation is
either able to renature back to its native state during the electrophoresis process or is capable of catalyzing the redox-cycling reaction itself. These results imply that copper may play a structural role in stabilizing the BLO in a conformation that maintains the LTQ
cofactor in its correct configuration. It is also possible that the
copper-related conformation in BLO may be important in binding of its
natural substrates, elastin and collagen molecules.
The Turnover of Benzylamine with the Apo-bovine Lysyl
Oxidase--
Table I shows that apoBLO containing 7% of its copper
retained 51% of reactive LTQ after correction for the residual copper content and the decrease of LTQ content. The presence of
To rule out the possibility that a trace amount of copper from the
assay buffer was contributing to the activity measured for the apoBLO,
two different concentrations of the apoBLO were used to conduct the
assays, and their activity was compared. As shown in Table
II, when the LTQ content of the diluted
apoBLO in the assay was 0.4 µM, the activity was 54% of
that of the native BLO after correction for the decrease of the LTQ and
for the residual copper content in the apoBLO. A similar activity (51%
of the native BLO activity) was obtained when 5-fold the amount of
apoBLO (2.0 µM LTQ) was used in the assay. The level of
trace Cu2+ in the assay buffer was measured to be <0.1
µM, which is 4-fold less than the LTQ when using 15.6 µg of protein and 20-fold below the LTQ level with the higher protein
concentration. One would expect higher specific activity to be
associated with the diluted apoBLO if trace copper from the buffer
contributed significantly to the activity measured. Thus, it is
unlikely that benzylamine activity observed with apoBLO arises from
trace copper contamination in the assay solution.
The data presented here argue against the requirement for copper in the
oxidation of benzylamine by BLO. In an earlier study of HPAO, Su and
Klinman (8) presented evidence that active site Cu2+ need
not change its valence state during turnover of amine substrates. This
view is supported by recent studies of Co2+-substituted
HPAO (9). For this TPQ-containing system, it has been proposed that the
active site metal plays a role as electrostatic catalyst in dioxygen
reduction to hydrogen peroxide. Evidence against an essential role for
metal in the oxidation of reduced quino-cofactors comes from model
studies of TPQ analogs, together with the fact that the tryptophan
tryptophylquinone-containing methylamine dehydrogenase can function
catalytically in the absence of active site metal (14). We have not yet
tested the catalytic ability of apoBLO using elastin or collagen as
substrate, and more detailed kinetic and spectroscopic studies will be
needed to establish that the mechanism of apoBLO is the same as the
native enzyme. However, the data presented within establish the ability of BLO to function in the absence of copper using a small substrate or
its analog. The well established physiological requirement for copper
in LO (3) is attributed to an essential role for copper in the
biogenesis of the LTQ cofactor and to a role for copper in the
maintenance of cofactor and/or protein structural integrity.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1 cm
1 as the molar extinction
coefficient. The BLO activity was typically 0.02-0.04 units/mg after
correction for the contaminating band. Unless specified specifically
that other methods were used, the protein concentration was measured
with Bio-Rad protein assay (Bradford assay) using bovine serum albumin
as a standard.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
The LTQ content, activity, and metal content of native and apoBLO

View larger version (14K):
[in a new window]
Fig. 1.
The UV-visible spectra of apoBLO in the
reaction with phenylhydrazine. A, in the presence of
2,2'-dipyridyl (DIP); B, after removal of
2,2'-dipyridyl by dialysis. Open triangles and
circles, before reaction with phenylhydrazine
(
PH); filled triangles and circles,
after reaction with phenylhydrazine (+PH).

View larger version (16K):
[in a new window]
Fig. 2.
Comparison of the UV-visible spectra of BLO
with and without the dialysis against a chelating buffer at pH
6.9. The chelating buffer contained 6 M urea, 10 mM 2,2'-dipyridyl, 16 mM KPi (pH 6.9). The
chelator was removed by dialysis as described under "Experimental
Procedures." A, before reaction with phenylhydrazine
(open triangles, without dialysis; open squares,
after dialysis); B, after the reaction with phenylhydrazine
(+PH; filled triangles, without dialysis;
filled squares, after dialysis). The apoBLO without
phenylhydrazine (
PH) is shown as a control (open
squares).

View larger version (77K):
[in a new window]
Fig. 3.
Redox staining of apoBLO that no longer
reacts with phenylhydrazine. 30 µl of BLO solution (0.67 mg/ml
of total protein stock) was used for each lane in SDS-PAGE
(12% gel). Protein transfer from the gel onto nitrocellulose paper
(0.45-µm membrane; Bio-Rad) was performed at 120 mA overnight. The
blot was stained with NBT as described by Paz et al. (15).
A, Coomassie Blue-stained gel; B, NBT-stained
membrane blot from a duplicated gel. Lane 1, native BLO;
lane 2, apoBLO. Protein markers were in the lanes
before lane 1 and after lane 2. The
band that runs faster than BLO in A is typically
co-purified with lysyl oxidase and has been previously identified as a
tyrosine-rich acidic matrix protein (16) that does not affect the
enzyme activity (7).
-aminopropionitrile, an active site inhibitor of native LO (13),
completely inhibited the apoBLO activity (data not shown). Incubation
of apoBLO with 4 µM Cu2+, which was
equivalent to the amount of reactive LTQ, at room temperature for 10 min did not increase the activity; however incubation at 4 °C for
48 h did increase the activity by 36% (data not shown), implying
that the reincorporation of copper at its original site may be slow.
Comparison of apoBLO activity assayed with two different enzyme
concentrations
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grant GM 39296 (to J. P. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Onyx Pharmaceuticals, 3031 Research Dr.,
Richmond, CA 94806.
§ To whom correspondence should be addressed. Tel.: 510-642-2668; Fax: 510-643-6232; E-mail: klinman@socrates.berkeley.edu.
Published, JBC Papers in Press, June 6, 2001, DOI 10.1074/jbc.C100138200
2 Manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: LO, lysyl oxidase; BLO, bovine lysyl oxidase; Pi, inorganic phosphate; PAGE, polyacrylamide gel electrophoresis; NBT, nitro blue tetrazolium; HPAO, Hansenula polymorpha expressed in Saccharomyces cerevisiae.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Pinnell, S. R., and Martin, G. R. (1968) Proc. Natl. Acad. Sci. U. S. A. 61, 708-716 |
| 2. | Kagan, H. M. (1986) in Biology of Extracellular Matrix (Mecham, R. P., ed), Vol. 1 , pp. 321-398, Academic Press, Orlando, FL |
| 3. | Kuivaniemi, H., Peltonen, L., Palotie, A., Kaitila, I., and Kivirikko, K. D. (1982) J. Clin. Invest. 69, 730-733 |
| 4. | Siegel, R. C., Pinnell, S. R., and Martin, G. R. (1970) Biochemistry 9, 4486-4492 |
| 5. | Harris, E. D., Gonnerman, W. A., Savage, J. E., and O'Dell, B. L. (1974) Biochim. Biophys. Acta 341, 332-344 |
| 6. | Gacheru, S. N., Trackman, P. C., Shah, M. A., O'Gara, C. Y., Spacciapoli, P., Greenaway, F. T., and Kagan, H. M. (1990) J. Biol. Chem. 265, 19022-19027 |
| 7. | Wang, S. X., Mure, M., Medzihradszky, K. F., Burlingame, A. L., Brown, D. E., Dooley, D. M., Smith, A. J., Kagan, H. M., and Klinman, J. P. (1996) Science 273, 1078-1084 |
| 8. | Su, Q., and Klinman, J. P. (1998) Biochemistry 37, 1251-12525 |
| 9. | Mills, S. A., and Klinman, J. P. (2000) J. Am. Chem. Soc. 122, 9897-9904 |
| 10. | Cai, P., and Kagan, H. M. (1995) Methods Enzymol. 258, 122-132 |
| 11. | Williamson, P. R., and Kagan, H. M. (1986) J. Biol. Chem. 261, 9477-9482 |
| 12. | Liu, G., Nellaiappan, K., and Kagan, H. M. (1997) J. Biol. Chem. 272, 32370-32377 |
| 13. | Tang, S.-S., Trackman, P. C., and Kagan, H. M. (1983) J. Biol. Chem. 258, 4331-4338 |
| 14. | Zhu, Z., and Davidson, V. L. (1998) Biochim. Biophys. Acta 1364, 297-300 |
| 15. | Paz, M. A., Fluckiger, R., Boak, A., Kagan, H. M., and Gallop, P. M. (1991) J. Biol. Chem. 266, 689-692 |
| 16. | Cronshaw, A. D., MacBeath, J. R. E., Shackleton, D. R., Collins, J. F., Fothergill-Gilmore, L. A., and Hulmes, D. J. S. (1993) Matrix 13, 255-266 |
| 17. | Williamson, P. R., and Kagan, H. M. (1987) J. Biol. Chem. 262, 8196-8201 |
This article has been cited by other articles:
![]() |
M. S. Kim, S.-S. Kim, S. T. Jung, J.-Y. Park, H.-W. Yoo, J. Ko, K. Csiszar, S.-Y. Choi, and Y. Kim Expression and Purification of Enzymatically Active Forms of the Human Lysyl Oxidase-like Protein 4 J. Biol. Chem., December 26, 2003; 278(52): 52071 - 52074. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |